Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Ali Z, O’Reilly S, Zahoor T, Schofield P, Malik Z (2008) Experience of febrile neutropaenia and secondary G-CSF prophylaxis during FEC_D chemotherapy in Merseyside and Cheshire Cancer Network. National Cancer Research Institute Cancer Conference; Abstract B67
2. Bonadonna G, Valagussa P, Moliternni A, Zambetti M, Brambilla C (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332: 901–906
3. Cancer Research UK (2009) UK breast cancer incidence statistics. Available at: http://info.cancerresearchuk.org/cancerstats/types/breast/incidence/ (accessed May 2009)
4. Chirivella I, Bermejo B, Insa A, Perez-Fidalgo A, Magro A, Rosello S, Garcia-Garre E, Martin P, Bosch A, Lluch A (2006) Impact of chemotherapy dose-related factors on survival in breast cancer patients treated with adjuvant anthracycline-based chemotherapy. J Clin Oncol 24: Abstract 668
5. Cullen M, Baijal S (2009) Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer 101(Suppl 1): S11–S14
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献